RxDoctor Payments Data

Stephanie Justin

Family · Lees Summit, MONPI 1467749481

Payments from drug & device makers

$7,350in general payments, 2019–2025

Across 292 payments — averaging $25.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • Bristol Myers Squibb$627
  • Johnson & Johnson$557
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$354
  • Merck$329
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$7,24699%
  • Education$1041%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,350 in reported general payments places this provider in the 95th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
StelaraUstekinumab14$400,128
Humira(Cf) PenAdalimumab11$149,204
TrulancePlecanatide21$12,084
LinzessLinaclotide15$12,010
Mesalamine17$5,721
Famotidine389$4,273
Mesalamine DrMesalamine11$4,225
Dexlansoprazole DrDexlansoprazole23$4,023
Colestipol Hcl33$3,631
Pantoprazole Sodium259$3,442
Balsalazide Disodium14$2,739
Lansoprazole15$2,335
Omeprazole107$1,037
Ondansetron OdtOndansetron39$561
Esomeprazole Magnesium12$455

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonStelara$557$400,12814 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$354$12,08421 claims
AbbVieLinzess$2,292$12,01015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,812 family providers in Missouri.

Other family in Lees Summit

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →